SynAct Pharma AB

SynAct Pharma is a pharmaceutical group that conducts research and development in the treatment of inflammatory diseases. The company has developed a platform technology that is aimed at severe conditions in chronic inflammatory diseases, and foremost joint injuries. The subsidiary SynAct Pharma Aps was initially founded in 2012 and the parent company was established in 2016. The head office is located in Lund.

Quotes for SynAct Pharma AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Jeppe Øvlesen

Chairperson of the Board

  • Torbjørn Bjerke

Board

  • Kerstin Hasselgren
  • Marina Bozilenko
  • Terje Kalland
  • Thomas Jonassen
  • Uli Hacksell
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Sedermeradagen Malmö 2018

    SynAct Pharma - Life Science-dagen 2018

    Styrelseordförande Torbjørn Bjerke på Aktiesparardagen i Lund

    Styrelseledamot Charlotte Edenhus på Sedermeradagen i Stockholm

    Largest Owners

    Name Capital % Votes % Date
    Thomas Jonassen 6,85 6,85 2024-03-21
    Avanza Pension 6,32 6,32 2024-03-26
    Nordnet Pensionsförsäkring 4,67 4,67 2024-03-26
    Thomas Ringberg 4,48 4,48 2024-04-12
    Thomas von Koch 3,14 3,14 2024-03-26
    Torbjörn Bjerke 2,95 2,95 2024-03-26
    Handelsbanken Fonder 2,27 2,27 2024-03-31
    Heights Capital Management Inc. 2,06 2,06 2024-03-26
    OR Invest A/S 0,90 0,90 2024-03-26
    SEB Fonder 0,88 0,88 2024-03-31

    Annual reports, prospectus etc.